FRANK DiLORENZO is an Investment Officer with Standard & Poor’s U.S.
Equity Research Division. He is S&P’s Biotechnology Analyst and is
responsible for the equity research of the biotechnology industry and
the life science instrument sector. Mr. DiLorenzo authors research
reports, company notes and a bi-annual survey on the biotech sector. He
has been featured in a number of media sources. He joined the S&P team
in May 1999 and has been covering biotech issues since the summer of
1999. He holds an MBA from Rutgers Graduate School of management, as
well as an undergraduate degree in Management from Rutgers. He is also a
registered representative of S&P Securities. His previous experience
includes working as a Fixed Income Analyst for Metropolitan Life.
